5/7/2023 0 Comments Twitter ticker confusion![]() (Jim Cramer's Charitable Trust is long LLY, COST, AMD, DHR and F. Look at Ulta Beauty (ULTA) instead, says analyst Oliver Chen. Kohl's (KSS) downgraded to hold from buy (market perform from outperform) at Cowen. My agent Endeavor (EDR) recommended by Bank of America, initiated with a buy rating and $28 per share price target. Provides financial infrastructure solutions for crypto industry. Silvergate Capital (SI) resilience within crypto rout. Stephens analyst Brian Colley now likes CrowdStrike (CRWD) as his Best Idea over Ping Identity (PING), which got a bid to be bought by Thoma Bravo. Crocs (CROX): quarterly revenue $965 million versus $937 million EPS adjusted $3.24 per share versus $2.66 expected. ConocoPhillips (COP): quarterly EPS $3.91 per share versus $3.80 expected. GXO Logistics (GXO) price target raised to $65 per share from $61 at Susquehanna. Walmart (WMT) jobs cut at corporate but we don't know what they are really doing. Animal health company Zoetis (ZTS) misses EPS but gets revenues right. Paramount Global (PARA), formerly ViacomCBS, is better than expected: quarterly adjusted earnings 64 cents per share versus 61 cents expected. All that ever happens is that they suck you in and then they crush you. Don't forget South America with big prices. Grains: The Wall Street Journal notes hedge funds leaving wheat corn and soy. Barclays raises price target at PayPal (PYPL) to $131 per share from $125. Downgraded by Baird to hold from buy (neutral from outperform), which also lowers price target to $10 per share from $12. Comeback challenged by economic headwinds. Baird goes to hold from buy (neutral from outperform) on Under Armour (UAA). Volatile second half, says Morgan Stanley. They have enough money before testing cash. EV start-up Fisker (FSR) cash consumption $191 million. The stock was set to open Thursday around $18. Citi lowers Lucid price target to $28 per share from $36. As a comparison, Ford (F) market cap is $63 billion Lucid is $34 billion. Delivered just 679 in the second quarter. Lots of orders including 100,000 from Saudi Arabia but supply chain and logistics felled them. Still too big a market cap because halves production target. Electric vehicle maker Lucid (LCID) cuts production targets, again stock losing 13% in the premarket, which would be on top of its 46% year-to-date loss. Gross merchandise value (GMV) has bottomed. Pace of Booking's reservations moderated to 4% growth. I don't think that Airbnb (ABNB) meant to say it, but it was being interpreted as such. It is not supported by anything, said Marriott (MAR). This is a new theme: growth of travel moderating. Booking Holdings (BKNG) – Priceline, OpenTable, Kayak – sees pace of growth moderating but the market loves It anyway. Thermo Fisher Scientific (TMO) joins Club holding Danaher (DHR) and CVS Health (CVS) to come out stronger post Covid. (HPQ) with that forecast, which is appreciably worse than Intel's. AMD CEO Lisa Su has de-risked, telling me that there will be double digit decline in PCs. Club holding Advanced Micro Devices (AMD): The tech titans will use its 5 nanometer processor and Intel (INTC) having trouble making last iteration. Analyst Kimberly Greenberger sees limited opportunity for positive earnings revisions. Big apparel downgrade: Levi Strauss (LEVI) goes to hold from buy (equal weight from overweight) at Morgan Stanley. Fortinet (FTNT), a cyber miss? Agco (AGCO), maker of farm machinery, chose Palo Alto Networks (PANW) after its hack to look in and change things. Full-year guidance for 7% to 8% organic growth had been 4% in prior outlook cash flow expected to be $1.2 billion, up from prior guidance. Kellogg (K) beat on quarterly earnings and revenue. Credit Suisse lowers its price target to $130 per share from $140. The company says excluding health and wellness it had organic growth of 5%. Clorox (CLX), no way around it, first-class disaster: Misses on pretty much every line item, sadly. Excluding gasoline prices and foreign exchange, U.S. Club holding Costco (COST) beats again: Total July comp sales rose 10%. Mounjaro also in trials for obesity treatment. Type-2 diabetes drug Mounjaro, just approved by the FDA in May, had $16 million in sales. Lilly gets expedited review of donanemab for Alzheimer's. 6% core growth just OK but great pipeline. ![]() Club holding Eli Lilly (LLY) warns on currency after total quarterly revenue of $6.49 billion misses. ![]() (also, no "Morning Meeting" for Thursday). ![]() 4, 2022 Gameday: The Club's "Monthly Meeting" livestream for members at noon ET.
0 Comments
Leave a Reply. |